Il-6 antagonist for use as mesothelioma therapeutic agent

Details Il-6 antagonist for use as mesothelioma therapeutic agent Il-6 antagonist for use as mesothelioma therapeutic agent

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 45/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2542691

A therapeutic agent for mesothelioma, comprising an interleukin-6 (IL-6) antagonist, for example, an antibody against IL-6 receptor (IL-6R); and a mesothelioma cytostatic agent comprising an IL-6 antagonist, for example, an antibody against IL-6R.

L'invention concerne un agent de traitement de mésothéliome, comprenant un antagoniste de l'interleukine-6 (IL-6), par exemple un anticorps du récepteur de l'IL-6 (IL-6R), ainsi qu'un agent cytostatique de mésothéliome comprenant un antagoniste de l'IL-6, par exemple un anticorps de l'IL-6R.

Affiliated with

Also associated with

Rating

Il-6 antagonist for use as mesothelioma therapeutic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Il-6 antagonist for use as mesothelioma therapeutic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Il-6 antagonist for use as mesothelioma therapeutic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2044865